Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 3Phase 2 3Phase 1/2 1Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Neoplasm Metastasis 3Carcinoma, Hepatocellular 3Uveal Melanoma 2Liver Neoplasms 2Colorectal Neoplasms 2Rectal Neoplasms 1Pelvic Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Leiomyoma 1Colonic Neoplasms 1Chylous Ascites 1Abdominal Neoplasms 1

Interventions

Bevacizumab 69Sorafenib 66lenvatinib 59durvalumab 38sintilimab 33Nivolumab 32tislelizumab 28atezolizumab 28pembrolizumab 27Oxaliplatin 26tremelimumab 23apatinib 22Fluorouracil 22Radiosurgery 20regorafenib 19camrelizumab 18Doxorubicin 18cabozantinib 16Leucovorin 16Capecitabine 16Radiotherapy 14Folfox protocol 14donafenib 13Gemcitabine 13Cisplatin 12toripalimab 11Erlotinib Hydrochloride 10spartalizumab 8anlotinib 8Neoadjuvant Therapy 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Hepatocellular × Embolization, Therapeutic × Clear all
NCT00003907 2023-07-05

Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

Eastern Cooperative Oncology Group

Phase 2 Completed
50 enrolled 8 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis

NCT00335829 2021-08-13

Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Yale University

Phase 2 Completed
26 enrolled 12 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03048123 2017-02-09

HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B

Sun Yat-sen University

Phase 2 Completed
79 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡